Skip to main content
Equibles

BARCLAYS PLC

Position in SYRE — Spyre Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,351,445
+$6,042,000 QoQ
Shares Held
94,069
+105.5% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 266 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. SYRE ranks #29 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in SYRE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,351,445 94,069
2026-03-31 $2,309,445 45,786
2025-12-31 $5,979,485 182,524
2025-09-30 $2,821,209 168,330
2025-06-30 $3,243,190 216,646
2025-03-31 $3,462,667 214,606
2024-12-31 $2,865,092 123,071
2024-09-30 $3,101,784 105,467
2024-06-30 $1,505,650 64,043
2024-03-31 $1,743,337 45,962
2023-12-31 $979,116 45,498